Filing Details
- Accession Number:
- 0001209191-13-018116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-22 18:40:21
- Reporting Period:
- 2013-03-20
- Filing Date:
- 2013-03-22
- Accepted Time:
- 2013-03-22 18:40:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1009356 | Salix Pharmaceuticals Ltd | SLXP | Pharmaceutical Preparations (2834) | 943267443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1301715 | A Mark Sirgo | 606 Wayne Street Raleigh NC 27608 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-03-20 | 3,000 | $50.05 | 28,955 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was pursuant to a Rule 10b5-1 Sales Plan dated December 3, 2012, which is intended to comply with Rule 10b5-1.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.03 to $50.08, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Billionaire Hedge Funds
